Group 2 (n = 555): GDM was diagnosed and treated in accordance with the current guidelines in 10.1% of all the women included, 74.0% of whom received management with lifestyle modifications, while 26.0% needed insulin therapy. This evidence concerns the gene INS and gestational diabetes.